Recovery Rate From Exertional Desaturation Is Associated With Disease Severity in Patients With Fibrotic Interstitial Lung Disease

被引：0
|
作者：
Tyker, A. [1 ]
Grant-Orser, A. [2 ]
Al-Saiedy, M. [2 ]
Keating, L. [3 ]
Adegunsoye, A. [3 ]
Johannson, K. A. [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Univ Chicago, Sect Pulm Crit Care, Chicago, IL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4976
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Workplace Productivity in Patients with Fibrotic Interstitial Lung Disease
    Algamdi, M.
    Sadatsafavi, M.
    Fisher, J. H.
    Morisset, J.
    Johannson, K. A. M.
    Fell, C. D.
    Kolb, M.
    Manganas, H.
    Cox, G.
    Gershon, A. S.
    Halayko, A. J.
    Hambly, N.
    Shapera, S.
    To, T.
    Khalil, N.
    Wilcox, P. G.
    Ryerson, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] Exertional Oxygen Supplementation Improves Leg Muscle Oxygenation and Neuromuscular Fatigue in Patients with Fibrotic Interstitial Lung Disease
    Marillier, M.
    Bernard, A.
    O'Donnell, D. E.
    Mendoza, O. Moran
    Verges, S.
    Neder, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Nocturnal Desaturation Is Associated with Pulmonary Hypertension in Patients with Mild to Moderate Interstitial Lung Disease
    Corte, T. J.
    Talbot, S.
    Wort, S. J.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [24] Qualitative aspects of exertional dyspnea in patients with interstitial lung disease
    O'Donnell, DE
    Chau, LKL
    Webb, KA
    JOURNAL OF APPLIED PHYSIOLOGY, 1998, 84 (06) : 2000 - 2009
  • [25] Factors associated with rapid progression in fibrotic interstitial lung disease
    Chen, Xianqiu
    Ji, Qiuliang
    Yao, Qian
    Zhou, Ying
    HELIYON, 2023, 9 (12)
  • [26] Progressive fibrotic interstitial lung disease
    Pereiraa, Carlos A. C.
    Corderoa, Soraya
    Resendea, Ana Carolina
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2023, 49 (05)
  • [27] Malignancy Risk Associated with Mycophenolate Mofetil and Azathioprine in Patients with Fibrotic Interstitial Lung Disease
    Lok, S. D.
    Wong, A. W.
    Cox, G. P.
    Fell, C. D.
    Fisher, J. H.
    Gershon, A. S.
    Halayko, A. J.
    Hambly, N.
    Khalil, N.
    Kolb, M. R.
    Manganas, H.
    Marcoux, V
    Morisset, J.
    Assayag, D.
    Sadatsafavi, M.
    Shapera, S.
    To, T.
    Wilcox, P.
    Ryerson, C. J.
    Johannson, K. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] Organic and Inorganic Exposures Are Associated With Radiologic Features in Patients With Fibrotic Interstitial Lung Disease
    Lok, S. D.
    Marinescu, D.
    Hague, C.
    Muller, N.
    Bilawich, A.
    Mayo, J.
    Sedlic, T.
    Ellis, J.
    Murphy, D.
    Leipsic, J.
    Churg, A. M.
    Wright, J. L.
    Al-Arnawoot, A.
    Haider, E.
    Tan, V.
    Bourgouin, P.
    Durand, C.
    Elliot, T.
    Guenther, Z.
    Huynh, J.
    Fladeland, D.
    Karjala, G.
    McInnis, M.
    Grant-Orser, A.
    Goobie, G. C.
    Khalil, N.
    Cox, G. P.
    Hambly, N.
    Kolb, M. R.
    Scallan, C. J.
    Macisaac, S.
    Marcoux, V.
    Manganas, H.
    Morisset, J.
    Shapera, S.
    Fisher, J. H.
    Sun, K.
    Zheng, B.
    Wong, A. W.
    Ryerson, C. J.
    Johannson, K. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [29] Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung Disease
    Lok, Stacey D.
    Wong, Alyson W.
    Khor, Yet H.
    Ryerson, Christopher J.
    Johannson, Kerri A.
    CHEST, 2022, 161 (06) : 1594 - 1597
  • [30] Longitudinal Evaluation and Subgroup Evaluation of Cough Severity in Fibrotic Interstitial Lung Disease
    Khor, Yet H.
    Ryerson, Christopher J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (09)
12345